David Annis

Chief Tech/Sci/R&D Officer at AILERON THERAPEUTICS, INC.

Net worth: 2 500 $ as of 30/03/2024

51 year

Health Technology

Consumer Services

Profile

David Allen Annis is currently the Senior Vice President-Research at Aileron Therapeutics, Inc. He previously worked as the Director-Technology Development at Schering-Plough Research Institute and as the Vice President-New Technologies at NeoGenesis Pharmaceuticals, Inc. Dr. Annis received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Georgia Institute of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AILERON THERAPEUTICS, INC. 0.01%	29/11/2023	377 ( 0.01% )	2 500 $	30/03/2024

David Annis active positions

Companies	Position	Start
AILERON THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	04/11/2018

All active positions of David Annis

Former positions of David Annis

Companies	Position	End
NeoGenesis Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA	Corporate Officer/Principal	-
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Corporate Officer/Principal	-

See the detail of David Annis's experience

Training of David Annis

Harvard University	Doctorate Degree
Georgia Institute of Technology	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Annis's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AILERON THERAPEUTICS, INC.	Health Technology

Private companies	2
NeoGenesis Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA	Health Technology
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Health Technology

See company connections